Devonian Health Group Inc.
GSD.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.15M | 16.68M | 13.21M | 7.34M | 3.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.15M | 16.68M | 13.21M | 7.34M | 3.86M |
| Cost of Revenue | 14.42M | 11.16M | 8.68M | 4.97M | 2.32M |
| Gross Profit | 6.73M | 5.52M | 4.52M | 2.36M | 1.54M |
| SG&A Expenses | 4.99M | 4.98M | 4.13M | 3.53M | 3.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 89.60K | 89.90K | 89.60K | 89.20K | 88.30K |
| Total Operating Expenses | 20.72M | 17.27M | 13.85M | 9.46M | 6.84M |
| Operating Income | 427.80K | -589.50K | -644.50K | -2.12M | -2.98M |
| Income Before Tax | 216.90K | -826.80K | -913.80K | -2.35M | -3.17M |
| Income Tax Expenses | 307.50K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.09 | -0.83 | -0.91 | -2.35 | -3.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -90.70K | -826.80K | -913.80K | -2.35M | -3.17M |
| EBIT | 427.80K | -589.50K | -644.50K | -2.12M | -2.98M |
| EBITDA | 866.10K | -135.00K | -176.90K | -1.83M | -2.68M |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 591.41M | 589.54M | 587.28M | 586.44M | 571.33M |
| Average Diluted Shares Outstanding | 591.41M | 589.54M | 587.28M | 586.44M | 571.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |